Hyperfine (HYPR) Gains from Sales and Divestitures (2022 - 2025)
Hyperfine (HYPR) reported Gains from Sales and Divestitures of $76160.0 for Q3 2025, down 30.79% on a YoY basis from $110041.0 in Q3 2024, and up 36.38% quarter-over-quarter from $55846.0 in Q2 2025.
Hyperfine (HYPR) Gains from Sales and Divestitures (2022 - 2025) Analysis & Trends
Hyperfine has reported Gains from Sales and Divestitures for 4 years, with the latest figure at $76160.0 in Q3 2025.
- For the quarter ending Q3 2025, Gains from Sales and Divestitures fell 30.79% year-over-year to $76160.0; the trailing twelve-month figure through Sep 2025 stood at $76160.0 (down 30.79% YoY), and the FY2022 full-year result was $33281.0, changed N/A from the prior year.
- Gains from Sales and Divestitures for Q3 2025 stood at $76160.0, up from $55846.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $754679.0 in Q3 2023, with the low at $19220.0 in Q2 2022.
- Historically, Gains from Sales and Divestitures has averaged $188903.2 across 4 years, with a median of $76114.5 in 2024.
- Annual changes were most pronounced in 2023 — Gains from Sales and Divestitures surged 2731.38% — and 2024, when it plunged 87.35%.
- Hyperfine's Gains from Sales and Divestitures stood at $33281.0 in 2022, then soared by 2167.6% to $754679.0 in 2023, then slumped by 85.42% to $110041.0 in 2024, then plunged by 30.79% to $76160.0 in 2025.
- The last three Gains from Sales and Divestitures figures came in at $76160.0 (Q3 2025), $55846.0 (Q2 2025), and $29143.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Hyperfine | 155.82 Mn | 114.55 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 76,160.00 |
| Sep 30, 2025 | 76,160.00 |
| Jun 30, 2025 | 55,846.00 |
| Jun 30, 2025 | 55,846.00 |
| Mar 31, 2025 | 29,143.00 |
| Mar 31, 2025 | 29,143.00 |
| Sep 30, 2024 | 110,041.00 |
| Sep 30, 2024 | 110,041.00 |
| Jun 30, 2024 | 76,069.00 |
| Jun 30, 2024 | 76,069.00 |
| Mar 31, 2024 | 41,036.00 |
| Mar 31, 2024 | 41,036.00 |
| Sep 30, 2023 | 754,679.00 |
| Sep 30, 2023 | 754,679.00 |
| Jun 30, 2023 | 544,191.00 |
| Jun 30, 2023 | 544,191.00 |
| Mar 31, 2023 | 324,296.00 |
| Mar 31, 2023 | 324,296.00 |
| Dec 31, 2022 | 33,281.00 |
| Dec 31, 2022 | 33,281.00 |